Followers | 507 |
Posts | 10138 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Friday, November 20, 2015 1:06:11 PM
bearish 26.75
## source: finance.yahoo.com
Fri, 13 Nov 2015 18:04:21 GMT ~ ESPERION THERAPEUTICS, INC. Financials
read full: http://finance.yahoo.com/q/is?s=espr
*********************************************************
Thu, 12 Nov 2015 23:49:17 GMT ~ Lightning Round: It's nowhere near bottoming yet
read full: http://www.cnbc.com/id/103164511?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=103164511
*********************************************************
Thu, 12 Nov 2015 23:25:00 GMT ~ Cramer: I'm staying away from solar
read full: http://finance.yahoo.com/video/cramer-im-staying-away-solar-232500149.html
*********************************************************
Fri, 06 Nov 2015 14:04:19 GMT ~ Esperion Therapeutics to Present at November Healthcare Conferences
[at noodls] - November 6, 2015 ANN ARBOR, MI -- (Marketwired) -- 11/06/15 -- Esperion Therapeutics, Inc.(NASDAQ: ESPR), a pharmaceutical company focused on developing and commercializing first-in-class, oral, low-density ...
read full: http://www.noodls.com/view/469E1EE69725B2494C35AFD0D6048130A1504775
*********************************************************
Fri, 06 Nov 2015 13:30:00 GMT ~ Esperion Therapeutics to Present at November Healthcare Conferences
[Marketwired] - Esperion Therapeutics, Inc. , a pharmaceutical company focused on developing and commercializing first-in-class, oral, low-density lipoprotein cholesterol lowering therapies for the treatment of patients ...
read full: http://finance.yahoo.com/news/esperion-therapeutics-present-november-healthcare-133000217.html
*********************************************************
$ESPR charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$ESPR company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/ESPR/company-info
Ticker: $ESPR
OTC Market Place: Not Available
CIK code: not found
Company name: Esperion Therapeutics, Inc.
Incorporated In:
Business Description:
$ESPR share structure
## source: otcmarkets.com
Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available
$ESPR extra dd links
Company name: Esperion Therapeutics, Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/ESPR/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/ESPR/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=ESPR+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=ESPR+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=ESPR+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/ESPR/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/ESPR/news - http://finance.yahoo.com/q/h?s=ESPR+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/ESPR/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/ESPR/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/ESPR/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/ESPR/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/ESPR/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/ESPR/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/ESPR/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/ESPR/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=ESPR+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/ESPR
DTCC (dtcc.com): http://search2.dtcc.com/?q=Esperion+Therapeutics%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Esperion+Therapeutics%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Esperion+Therapeutics%2C+Inc.&x=0&y=0
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/ESPR/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/ESPR
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/ESPR/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/ESPR/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/ESPR/sec-filings
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/ESPR/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/ESPR/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/ESPR/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/ESPR/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=ESPR&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=ESPR
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/ESPR/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=ESPR+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=ESPR+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=ESPR
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=ESPR
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=ESPR+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/ESPR/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=ESPR+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/ESPR.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=ESPR
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/ESPR/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/ESPR/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/ESPR/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/ESPR/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/ESPR
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/ESPR
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/ESPR:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=ESPR
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=ESPR
$ESPR DD Notes ~ http://www.ddnotesmaker.com/ESPR
Recent ESPR News
- Esperion Presents Important New Data from CLEAR Outcomes at ACC.24 Highlighting Value of NEXLETOL® (bempedoic acid) Tablets in Diverse Populations Including Women, Hispanics/Latinx and Patients with Obesity • GlobeNewswire Inc. • 04/07/2024 06:45:00 PM
- Esperion to Ring Nasdaq Opening Bell Today, April 1, 2024 • GlobeNewswire Inc. • 04/01/2024 12:00:00 PM
- Esperion to Participate in 23rd Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 03/26/2024 12:00:00 PM
- Esperion Announces Data from CLEAR Outcomes Sub-Groups as Poster Presentations, Moderated Session & Industry Expert Theatre to be Presented at ACC.24 • GlobeNewswire Inc. • 03/25/2024 08:00:00 PM
- U.S. FDA Approves Broad New Labels for Esperion’s NEXLETOL® and NEXLIZET® to Prevent Heart Attacks and Cardiovascular Procedures in Both Primary and Secondary Prevention Patients, Regardless of Statin Use • Business Wire • 03/22/2024 10:26:00 PM
- U.S. FDA Approves Broad New Labels for NEXLETOL® and NEXLIZET® to Prevent Heart Attacks and Cardiovascular Procedures in Both Primary and Secondary Prevention Patients, Regardless of Statin Use • GlobeNewswire Inc. • 03/22/2024 07:10:20 PM
- CHMP Issues Positive Opinions For Both Bempedoic Acid And The Bempedoic Acid / Ezetimibe Fixed-Dose Combination Tablet As Treatments For Hypercholesterolemia And Significantly Reducing Cardiovascular Events • GlobeNewswire Inc. • 03/22/2024 03:04:39 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/27/2024 02:19:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 12:23:29 PM
- Esperion Reports Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 02/27/2024 11:00:00 AM
- Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 02/16/2024 09:30:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 07:14:47 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 03:50:20 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 01:42:23 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 11:11:31 AM
- Esperion to Report Fourth Quarter and Full Year 2023 Financial Results on February 27 • GlobeNewswire Inc. • 02/13/2024 01:00:00 PM
- RFK, Esperion Therapeutics Announce 2024 Promotional Schedule • GlobeNewswire Inc. • 02/01/2024 07:00:00 PM
- Esperion Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares • GlobeNewswire Inc. • 01/23/2024 09:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 11:10:03 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 01/22/2024 11:04:57 AM
- Esperion Announces Pricing of $85.1 Million Public Offering of Common Stock • GlobeNewswire Inc. • 01/19/2024 02:15:58 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/18/2024 09:03:07 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 01/18/2024 09:01:29 PM
- Esperion Announces Proposed Public Offering of Common Stock • GlobeNewswire Inc. • 01/18/2024 09:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/11/2024 09:09:45 PM
FEATURED Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • Apr 17, 2024 8:00 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM
Kona Gold Beverages, Inc. Acquires Surge Distribution LLC from Loud Beverage Group, Inc. (LBEV) • KGKG • Apr 16, 2024 8:30 AM
Branded Legacy, Inc. Reports Significant Net Income of Over $3.8 Million • BLEG • Apr 16, 2024 8:30 AM